Clinical Trial

Neuroblastoma Biology Study

Recruiting
View on ClinicalTrials.gov →
Summary
Medical scientists want to find better ways to treat neuroblastoma and to find ways to prevent the tumor from growing back. To do this, they need more information about the characteristics of neuroblastoma cells. Therefore, they want to study samples of neuroblastoma tissues and neuroblastoma and normal cells in the blood and bone marrow that may be related to the growth of neuroblastoma cells. Doctors and other medical scientists also want to find better ways to detect and measure neuroblastoma to improve the ability to follow the response of tumor cells to therapy.
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2012-04-27; most recent amendment 2026-03-19.
Trial Details
NCT Number NCT01587300
Lead Sponsor New Approaches to Neuroblastoma Therapy Consortium
Conditions Neuroblastoma
Enrollment 1,000 participants
Start Date 2011-07
Primary Completion 2099-12 (estimated)
Study Completion 2099-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-23